DARREN SCHULTE, M.D., M.P.P, JOINS ANVITA HEALTH

SAN DIEGO, Dec. 8, 2010 - Darren Schulte, M.D., M.P.P., has joined clinical analytics pioneer Anvita Health as vice president of Clinical Strategy. In this new role, Schulte will direct Anvita Health's overall clinical and product strategy efforts, and align the company's solution development with the evolving health care business and regulatory environments in which clinical data will play an increasingly critical role. 

"Darren's unique background in clinical analytics and care management will be instrumental in evolving Anvita Health's solution suite," said Anvita Health CEO Richard Noffsinger. "His appointment fortifies our leadership in intelligently leveraging clinical data to improve clinical outcomes and control costs." 

Prior to joining Anvita Health, Schulte was with Alere Health, where he held executive positions related to clinical product strategy and development. Previous to Alere, Schulte was with Resolution Health as director of Clinical Affairs and Analytics. Schulte obtained his medical degree from Stanford University and his Master of Public Policy from Harvard University. 

# # # 

About Anvita Health: Founded by physicians in 2000, Anvita Health provides innovative clinical analytics to its customer partners who, combined, cover more than 100 million lives. Anvita Health provides a high-performance clinical analytics engine for health plans, pharmacy benefit managers, personal health record and electronic health record companies, and health care providers. Anvita Health is headquartered in San Diego, California. 

For more information, contact:            Hal Mackins, Torch Communications, LLC

617-379-3775

[email protected]

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.